Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Neutral

Debt to Equity Rating

Neutral

Price to Earnings Rating

Strong Buy

Analyst Rating

Neutral

Simple Moving Average

Sell

Exponential Moving Average

Sell

Relative Strength Index

Neutral

Standard Deviation

Buy

Williams %R

Strong Buy

Average Directional Index

Neutral

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

LAVA Therapeutics N.V. Ordinary Shares (LVTX)

https://www.lavatherapeutics.com

LAVA Therapeutics NV is a biotechnology company. It is focused on transforming cancer treatment by developing a platform of novel bispecific antibodies designed to selectively induce gamma-delta T cell-mediated immunity against tumor cells.

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

03/25/2021

Market Cap

46,800,116

Shares Outstanding

26,290,000

Weighted SO

26,289,087

Total Employees

N/A

Upcoming Earnings

08/27/2024

Beta

0.5320

Last Div

0.0000

Range

1.131-6.47

Chg

0.0200

Avg Vol

72133

Mkt Cap

46800116

Exch

NASDAQ

Country

NL

Phone

31 630 00 30 35

DCF Diff

5.0992

DCF

-2.5255

Div Yield

0.0000

P/S

3.7330

EV Multiple

-0.3377

P/FV

0.9414

Div Yield %

0.0000

P/E

-1.6684

PEG

-0.1068

Payout

0.0000

Current Ratio

7.4206

Quick Ratio

7.4206

Cash Ratio

3.3152

DSO

26.4062

DIO

0.0001

Op Cycle

26.4064

DPO

448.1976

CCC

-421.7912

Gross Margin

0.7767

Op Margin

-2.5258

Pretax Margin

-2.2581

Net Margin

-2.2802

Eff Tax Rate

-0.0098

ROA

-0.2885

ROE

-0.5190

ROCE

-0.3680

NI/EBT

1.0098

EBT/EBIT

0.8940

EBIT/Rev

-2.5258

Debt Ratio

0.0619

D/E

0.1210

LT Debt/Cap

0.0076

Total Debt/Cap

0.1080

Int Coverage

0.0000

CF/Debt

-5.1797

Equity Multi

1.9556

Rec Turnover

13.8225

Pay Turnover

0.8144

Inv Turnover

999999.9999

FA Turnover

5.8176

Asset Turnover

0.1265

OCF/Share

-1.1854

FCF/Share

-1.1937

Cash/Share

3.5296

OCF/Sales

-2.5335

FCF/OCF

1.0070

CF Coverage

-5.1797

ST Coverage

-5.5286

CapEx Coverage

-143.5610

Div&CapEx Cov

-143.5610

P/BV

0.9414

P/B

0.9414

P/S

3.7330

P/E

-1.6684

P/FCF

-1.4633

P/OCF

-1.5016

P/CF

-1.5016

PEG

-0.1068

P/S

3.7330

EV Multiple

-0.3377

P/FV

0.9414

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation